researching the key technologies of prevention, screening, diagnosis and treatment of Alzheimer's disease
QANKOREY
Qankorey Technology Co.,Ltd, founded in 2014, is a Sino-foreign joint venture focusing on the crucial technological research of Alzheimer Disease, which is a medical thorny problem.
Globally, Qankorey is the first medical device for early screening of dementia using urine. We are a national high-tech enterprise, as well as a governing institution of China Association for Alzheimer's Disease.
R&D Center
Changsha R&D center
The head-quarter and domestic R&D center are in Changsha. The equipment of the R&D center has been invested over 50 millions, covering 2000 squares, and the annual output is planning to reach 2 billion yuan. There are three 10,000 degree clean workshops and one 100,000 degree clean workshops.
Melbourne R&D Center
Melborne R&D center focuses on the translational research in novel diagnostic products and new treatment methods for neurodegenerative diseases and cancer/leukemia.
Teams
The team in Melbourne consists of 7 doctors. Ben Gu, phD Supervisor, is the chief scientist of Qankorey. He has worked in senile dementia over 10 years. Besides, he is the founder of innate phgocytosis.
PROSPECT
We devote ourselves to be the server of AD field, and our mission is to help aged people to live well and live longer.
Besides, we are focusing on providing a integrated comprehensive solution for AD and other types of dementia, including the prevention, prediction, intervention and treatment of age-related disorders.
